JPRN-UMIN000030618Completed未知
Biomarker testing for Personalized Therapy in real world setting; First line treatment decision in the advanced non-squamous NSCLC - BRAVE-Study Biomarker testing for Personalized Therapy in real world setting; First line treatment decision in the advanced non-squamous NSCLC
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- AstraZeneca K.K.
- Enrollment
- 200
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1.Patients with postoperative recurrence 2.Patients enrolled in clinical trials of an unapproved drug as first-line therapy for advanced NSCLC 3.Patients otherwise considered unsuitable to participate in this study by investigators at study sites
Investigators
Similar Trials
Recruiting
Not Applicable
Genetic Biomarker Research for Personalized Therapy of Chorioretinal Neovascular DiseasesDiseases of the eye and adnexaKCT0001055Inje University Busan Paik Hospital1,000
Recruiting
Not Applicable
Biomarker discovery and development of therapy for aortic aneurysmAortic aneurysmJPRN-UMIN000010927Yokohama City University Graduate School of Medicine150
Completed
Not Applicable
A study of cell signalling biomarkers in patients with tuberous sclerosisISRCTN62388748Aeovian Pharmaceuticals Inc.14
Recruiting
Not Applicable
Validation for clinical utility of biomarkers for the early diagnosis of breast cancerKCT0005212Seoul National University Hospital496
Recruiting
Not Applicable
Establishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1)Steinerts disease10029299DM1NL-OMON50021Radboud Universitair Medisch Centrum20